Jim Cramer Thinks Axsome Therapeutics Inc (NASDAQ:AXSM) Stock Can Double
Jim Cramer in his latest program talked about how the China factor is affecting US stocks.
Axsome Therapeutics Inc. (AXSM)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Deep Track Capital David Kroin | 1,852,784 | $149,149,112 | +43% | 4.45% |
| 2. | RA Capital Management Peter Kolchinsky | 1,000,000 | $80,500,000 | 1.06% | |
| 3. | Biotechnology Value Fund / BVF Inc Mark Lampert | 955,000 | $76,877,500 | 2.15% | |
| 4. | Citadel Investment Group Ken Griffin | 753,237 | $60,635,579 | -35% | 0.01% |
| 5. | Millennium Management Israel Englander | 739,819 | $59,555,430 | -1% | 0.02% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $37.30 | 3,950 | Director | 120,756 | 2021-11-19 | Filing | |
| $35.20 | 142 | Officer | 142 | 2021-11-18 | Filing | |
| $34.30 | 145 | Officer | 145 | 2021-11-18 | Filing | |
| $35.43 | 141 | Officer | 201 | 2021-11-18 | Filing | |
| $35.50 | 527 | Officer | 41,789 | 2021-11-18 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $91.31 | 11,016 | 10,002 | 2024-09-11 | Filing | ||
| $84.26 | 47,739 | 5,783 | 2024-08-09 | Filing | ||
| $74.31 | 7,910 | 5,783 | 2024-05-29 | Filing | ||
| $75.14 | 5,248 | 14,600 | 2024-05-29 | Filing | ||
| $75.21 | 5,249 | 19,848 | 2024-05-28 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 4,489,596 | $357,326,946 | 5.58% | |
| 2. | 3,696,766 | $294,225,606 | 0% | |
| 3. | 3,239,746 | $257,851,385 | 0% | |
| 4. | 2,360,077 | $187,838,528 | 19.84% | |
| 5. | 924,190 | $73,556,282 | 0% |
News See All
Axsome Therapeutics, Inc. (NASDAQ:AXSM) Q2 2024 Earnings Call Transcript
Axsome Therapeutics, Inc. (NASDAQ:AXSM) Q2 2024 Earnings Call Transcript August 5, 2024Axsome Therapeutics, Inc. misses on earnings expectations.
Jim Cramer Latest Portfolio: 10 Stocks to Buy and Sell
Jim Cramer in his latest program talked about how the China factor is affecting US stocks.
Axsome Therapeutics, Inc. (NASDAQ:AXSM) Q1 2024 Earnings Call Transcript
Axsome Therapeutics, Inc. misses on earnings expectations. Reported EPS is $-1.44233 EPS, expectations were $-1.2. Axsome Therapeutics, Inc.
Wall Street Analysts See Upside Potential for 5 Stocks with Rising Price Targets
In this article, we will discuss the 10 stocks whose price targets were recently raised by analysts.
11 Oversold NASDAQ Stocks To Buy Right Now
In this article, we will be taking a look at 11 oversold NASDAQ stocks to buy right now.
11 Oversold Healthcare Stocks To Buy Right Now
In this article, we will be taking a look at 11 oversold healthcare stocks to buy right now.
Axsome Therapeutics, Inc. (NASDAQ:AXSM) Q4 2023 Earnings Call Transcript
Axsome Therapeutics, Inc. misses on earnings expectations. Reported EPS is $-2.08 EPS, expectations were $-1.21. Axsome Therapeutics, Inc.
11 Best Upside Stocks To Buy Right Now
The art of buying shares on the market has always gone hand in hand with share price analysis. A share price, in its simplest form, is the market's estimate of the company's future.
Axsome Therapeutics, Inc. (NASDAQ:AXSM) Q3 2023 Earnings Call Transcript
Operator: Good morning and welcome to Axsome Therapeutics Third Quarter 2023 Financial Results Conference Call. Currently, all participants are in a listen-only mode.